LaBarre Michael J.

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
45
Insider Sells Sum
$22.64M

Insider Activity of LaBarre Michael J.

According to the SEC Form 4 filings, LaBarre Michael J., being in a position of

  1. SVP, CHIEF TECHNICAL OFFICER at Halozyme Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 180000 shares for $8.81M,
    over all time since 2020-05-20, has bought 0 shares, and sold 525810 shares for $22.64M.

The largest sale of all time was on 2021-07-01 and amounted to 40315 shares of Halozyme Therapeutics, Inc. for $1.84M.

Biography of LaBarre Michael J.

No biography is available at this moment.

2024-10-16SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF TECHNICAL OFFICER
10,000
0.0074%
$53.26$532,590-9.08%
2024-10-15SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF TECHNICAL OFFICER
10,000
0.0075%
$53.75$537,469-9.68%
2024-09-18SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF TECHNICAL OFFICER
10,000
0.0079%
$62.03$620,316-16.92%
2024-09-17SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF TECHNICAL OFFICER
10,000
0.008%
$62.88$628,780-16.11%
2024-08-21SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF TECHNICAL OFFICER
10,000
0.0078%
$61.75$617,470-12.93%
2024-08-20SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF TECHNICAL OFFICER
10,000
0.0079%
$61.05$610,550-9.1%
2024-07-24SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF TECHNICAL OFFICER
10,000
0.0079%
$55.12$551,150+1.55%
2024-07-23SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF TECHNICAL OFFICER
10,000
0.0078%
$54.89$548,873+1.97%
2024-06-18SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF TECHNICAL OFFICER
10,000
0.0078%
$49.43$494,260+8.1%
2024-05-22SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF TECHNICAL OFFICER
10,000
0.0078%
$45.38$453,840+17.49%
2024-05-21SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF TECHNICAL OFFICER
10,000
0.0078%
$45.16$451,640+16.86%
2024-04-17SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF TECHNICAL OFFICER
10,000
0.008%
$38.49$384,890+34.93%
2024-04-16SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF TECHNICAL OFFICER
10,000
0.0079%
$38.35$383,500+33.16%
2024-03-13SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF TECHNICAL OFFICER
10,000
0.0081%
$42.27$422,730+19.85%
2024-03-12SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF TECHNICAL OFFICER
10,000
0.0078%
$41.64$416,370+18.03%
2024-02-28SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF TECHNICAL OFFICER
10,000
0.0079%
$39.55$395,463+22.46%
2024-02-27SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF TECHNICAL OFFICER
10,000
0.0079%
$39.95$399,460+21.99%
2024-01-17SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF TECHNICAL OFFICER
10,000
0.0076%
$36.00$360,000+30.88%
2023-12-13SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF TECHNICAL OFFICER
10,000
0.0073%
$40.39$403,940+5.55%
2023-12-12SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF TECHNICAL OFFICER
10,000
0.0075%
$39.63$396,322+9.49%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.